Background: Up to 80 % of the bariatric surgery (BS) patients suffer from obstructive sleep apnea (OSA). BS patients with moderate to severe OSA (apnea-hypopnea index (AHI) ≥15) are usually treated with continuous positive airway pressure (CPAP). This is not indicated in mild OSA patients (AHI <15). However, >50 % of patients with mild OSA have positional OSA (POSA); their AHI is at least twice as high in supine sleeping position than in other positions. Since many patients sleep in supine position for surgical safety reasons after BS, evaluating the AHI in this position might be more relevant in this group. The aim of this study is to evaluate the postoperative cardiopulmonary complication rate in mild OSA patients with and without POSA. Secondary aim is to evaluate predictive factors for POSA.

Methods: A single-institute retrospective analysis was achieved with all consecutive patients who underwent primary laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy between 2006 and 2014. All patients with an AHI between 5 and 15 were included. Postoperative complications were compared between POSA and non-POSA patients. Predictive factors were evaluated through univariate and multivariable logistic regression analysis.

Results: A total of 277 patients, 153 with and 124 without POSA, were included. After BS, three patients (1.1 %) experienced severe cardiopulmonary complications. No significant difference was found between POSA and non-POSA patients. In multivariate analysis, age and BMI were found to be negative predictors for POSA.

Conclusion: In terms of 30-day postoperative cardiopulmonary outcome, CPAP therapy is not indicated in mild (P)OSA patients scheduled for BS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11325-015-1192-0DOI Listing

Publication Analysis

Top Keywords

patients
14
postoperative cardiopulmonary
12
osa patients
12
mild osa
12
obstructive sleep
8
sleep apnea
8
bariatric surgery
8
surgery patients
8
indicated mild
8
patients ahi
8

Similar Publications

Background: The common drugs used for the treatment of Newly Diagnosed Multiple Myeloma (NDMM) include bortezomib and lenalidomide, but the adverse effects of lenalidomide cannot be ignored, especially when it is used in the initial therapy.

Methods: This retrospective study evaluated the efficacy and safety of a modified DVD regimen (pegylated liposomal doxorubicin, bortezomib, and dexamethasone) followed by lenalidomide in the treatment of NDMM. A total of 40 NDMM patients were treated with a reduced dose of pegylated liposomal doxorubicin (20 mg/m) on day 1, subcutaneous bortezomib (1.

View Article and Find Full Text PDF

Objective: TRIB3 has been confirmed to participate in and regulate biological metabolic activities in head and neck tumors such as nasopharyngeal carcinoma and oropharyngeal carcinoma, so the purpose of this study was to explore whether there is a correlation between TRIB3 and Laryngeal Squamous Cell Carcinoma (LSCC) and to preliminarily explore the biological characteristics of TRIB3 in LSCC.

Methods: TRIB3 expression in the LSCC was analyzed based on The Cancer Genome Atlas (TCGA) database. CCK-8 assay, Colony Formation Assay, wound healing assay, and Transwell assay were performed to investigate the roles of TRIB3 in the proliferation, invasion and metastasis of LSCC.

View Article and Find Full Text PDF

Health Expenditures of Patients With Diabetes After Bariatric Surgery: Comparing Gastric Bypass and Sleeve Gastrectomy.

Ann Intern Med

January 2025

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California (A.B., K.J.C., A.A.K.).

Background: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) differ in their effects on body weight and risk for reoperation. However, it is unclear whether long-term health expenditures differ by procedure type in patients with diabetes.

Objective: To compare health expenditures 3 years before and 5.

View Article and Find Full Text PDF

Background: Prior studies indicate that 1% to 4% of Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R-) kidneys develop posttransplant lymphoproliferative disorder (PTLD). However, these estimates are based on limited data that lack granularity.

Objective: To determine the associations between pretransplant EBV D+/R- and recipient EBV-seropositive status (R+) and the outcomes of PTLD and graft and patient survival among adult kidney transplant recipients.

View Article and Find Full Text PDF

Guidelines International Network: Principles for Use of Artificial Intelligence in the Health Guideline Enterprise.

Ann Intern Med

January 2025

Clinical Epidemiology and Research Center (CERC), Department of Biomedical Sciences, Humanitas University, and IRCCS Humanitas Research Hospital, Milan, Italy, and Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany (H.J.S.).

Description: Artificial intelligence (AI) has been defined by the High-Level Expert Group on AI of the European Commission as "systems that display intelligent behaviour by analysing their environment and taking actions-with some degree of autonomy-to achieve specific goals." Artificial intelligence has the potential to support guideline planning, development and adaptation, reporting, implementation, impact evaluation, certification, and appraisal of recommendations, which we will refer to as "guideline enterprise." Considering this potential, as well as the lack of guidance for the use of AI in guidelines, the Guidelines International Network (GIN) proposes a set of principles for the development and use of AI tools or processes to support the health guideline enterprise.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!